Tina Vilsbøll
Clinical Professor
Department of Clinical Medicine
Niels Steensens Vej 2-4, 2820 Gentofte
Member of:
Internal Medicine: Endocrinology
- Published
Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasis
Gyldenløve, M., Vilsbøll, Tina, Holst, Jens Juul, Zachariae, Claus, Skov, L. & Knop, Filip Krag, Nov 2016, In: British Journal of Dermatology. 175, 5, p. 1085–1088Research output: Contribution to journal › Letter › Research › peer-review
- Published
Diverse hepatic microbial DNA fingerprints in healthy lean and obese steatotic humans
Bagger, J. I., Suppli, M. P., Nielsen, T., Lelouvier, B., Broha, A., Demant, M., Konig, M. J., Strandberg, C., Lund, A., Vilsbøll, Tina & Knop, Filip Krag, 2018, In: Diabetologia. 61, p. S120-S121Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: Study protocol of a randomised, double-blinded, placebo-controlled clinical trial
Antonsen, K. K., Klausen, M. K., Brunchmann, A. S., le Dous, N., Jensen, M. E., Miskowiak, Kamilla, Fisher, Patrick Mac Donald, Thomsen, G. K., Rindom, H., Fahmy, T. P., Vollstaedt-Klein, S., Benveniste, H., Volkow, N. D., Becker, U., Ekstrøm, Claus Thorn, Knudsen, Gitte Moos, Vilsbøll, Tina & Fink-Jensen, Anders, Sep 2018, In: BMJ Open. 8, 7, 8 p., e019562.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES
Lingvay, I., Handelsman, Y., Linjawi, S., Vilsbøll, Tina, Halladin, N., Ranc, K. & Liebl, A., 2019, In: Endocrine Practice. 25, 2, p. 144-155Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial
Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Svensson, C. K., Koyuncu, K., Schjerning, O., Oturai, P. S., Kjær, Andreas, Nielsen, J., Holst, Jens Juul, Ekstrøm, Claus Thorn, Correll, C. U., Vilsbøll, Tina & Fink-Jensen, Anders, 1 Jul 2017, In: J A M A Psychiatry. 74, 7, p. 719-728 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion
Hansen, M., Scheltema, M. J., Sonne, David Peick, Hansen, J. S., Sperling, M., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Jun 2016, In: Diabetes, Obesity and Metabolism. 18, 6, p. 571-80 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial
Jørgensen, P. G., Jensen, M. T., Mensberg, P., Storgaard, H., Nyby, S., Jensen, J. S., Knop, Filip Krag & Vilsbøll, Tina, 2017, In: Diabetes, Obesity and Metabolism. 19, 7, p. 1040-1044Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial
Johansen, N. J., Dejgaard, T. F., Lund, A., Schluentz, C., Larsen, E. L., Poulsen, Henrik Enghusen, Goetze, Jens P. , Møller, H. J., Vilsbøll, Tina, Andersen, H. U. & Knop, Filip Krag, 2020, In: Diabetes, Obesity and Metabolism. 22, 9, p. 1639-1647Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis
Rohde, U., Hedbäck, N., Gluud, Lise Lotte, Vilsbøll, Tina & Knop, Filip Krag, Mar 2016, In: Diabetes, Obesity and Metabolism. 18, 3, p. 300-5 6 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Sass, M. R., Danielsen, A. A., Köhler-Forsberg, O., Storgaard, H., Knop, Filip Krag, Nielsen, Mette Ødegaard, Sjödin, Anders Mikael, Mors, O., Correll, C. U., Ekstrøm, Claus Thorn, Vinberg, Maj, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2023, In: BMJ Open. 13, 1, 10 p., e068652.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 33056950
Most downloads
-
372
downloads
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
303
downloads
Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
293
downloads
Dietary habits and adherence to dietary recommendations in patients with type 1 and type 2 diabetes compared with the general population in Denmark
Research output: Contribution to journal › Journal article › Research › peer-review
Published